Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SP-A
is an abundant
pulmonary surfactant-associated protein
whose expression is controlled in a cell- and developmental-specific manner. To analyze regulation of
SP-A
gene expression, the murine
SP-A
gene was cloned and sequenced. The murine DBA/2J gene was approximately 4.6 kb in length comprised of six exons and five introns. Three mRNAs of 3.0, 1.7, and 0.9 kb were detected by Northern blot analysis of murine lung mRNA. Expression of the
SP-A
mRNAs was first detected at day 15 of gestation and increased dramatically before birth. A single
SP-A
gene was detected in the DBA/2J mouse genome.
SP-A
mRNA was detected in lung but not in the gastrointestinal tract, kidney, brain, liver, or heart and was detected by in situ hybridization in bronchial and alveolar cells of the murine lung. Primer extension analysis with a primer to exon three revealed two extension products differing by 9 bp in length, suggesting two closely juxtaposed transcription initiation sites. Chimeric gene(s) containing 1.8 kb of 5'
SP-A
sequences and the bacterial
chloramphenicol acetyltransferase
gene were expressed in pulmonary adenocarcinoma cells and in HeLa cells. Expression of the murine
SP-A
gene is partially controlled by non-cell-selective transcriptionally active sequences.
...
PMID:Murine pulmonary surfactant SP-A gene: cloning, sequence, and transcriptional activity. 144 58
Cellular nuclease activity is a potential barrier to the successful delivery of foreign genes to mammalian cells. We tested the hypothesis that transfection in the presence of a specific DNase inhibitor can enhance the expression of foreign gene products. We have used DMI-2, a polyketide metabolite of Streptomyces sp. strain 560 to enhance the expression of bacterial
chloramphenicol acetyltransferase
(
CAT
) in the human lung adenocarcinoma cell line H441. DMI-2 has been shown previously to inhibit porcine DNase II, an acid pH nuclease contained in the endosomal/lysosomal compartment. Transfection of H441 cells in the presence of 0.1-1 microgram/ml DMI-2 caused: (1) 10-fold enhancement of
CAT
activity when the bacterial plasmid was complexed with either surfactant protein A-poly-lysine or transferrin-poly-lysine; (2) 1.5- to two-fold enhancement of
CAT
activity in cells exposed to lipofectin-DNA complexes: (3) no effect on transfection via calcium phosphate co-precipitation. DMI-2 alone showed no inherent transfection activity. In experiments using
SP-A
-poly-lysine and plasmid containing the beta-galactosidase reporter gene, DMI-2 increased the number of transfected cells. Methanolysis products of DMI-2 did not inhibit DNase II and did not enhance transfection efficiency. Taken together, the data support the hypothesis that nuclease action is a significant barrier to expression of foreign genes and inhibition of specific nucleases may facilitate transfection.
...
PMID:Enhanced reporter gene expression in cells transfected in the presence of DMI-2, an acid nuclease inhibitor. 993 Mar 26
The synthetic glucocorticoid dexamethasone has a major inhibitory effect on human surfactant protein A1 (SP-A1) and SP-A2 gene expression that occurs at both the transcriptional and posttranscriptional levels. Toward the identification of cis-acting elements that may be involved in the dexamethasone regulation of
SP-A
mRNA stability, chimeric
chloramphenicol acetyltransferase
(
CAT
) constructs that contained various portions of SP-A1 or SP-A2 cDNA in place of the native
CAT
3'-untranslated region (UTR) were transiently transfected into the lung adenocarcinoma cell line NCI-H441.
CAT
activity was reduced in NCI-H441 cells by exposure to 100 nM dexamethasone only for the chimeric
CAT
constructs that contained the
SP-A
3'-UTR. Moreover, the inhibitory response seen with dexamethasone was greater for the 3'-UTR derived from the SP-A1 allele 6A3 than with the 3'-UTR derived from either the SP-A1 allele 6A2 or SP-A2 allele 1A0, indicating differential regulation between
SP-A
genes and/or alleles.
...
PMID:SP-A 3'-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. 1036 15